期刊
VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE
卷 33, 期 1, 页码 67-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cveq.2016.11.002
关键词
Rhodococcus equi; Pneumonia; Macrolide; Rifampin
Pneumonia caused by Rhodococcus equi remains an important cause of disease and death in foals. The combination of a macrolide (erythromycin, azithromycin, or clarithromycin) with rifampin remains the recommended therapy for foals with clinical signs of infection caused by R equi. Most foals with small, subclinical ultrasonographic pulmonary lesions associated with R equi recover without therapy, and administration of antimicrobial agents to these subclinically affected foals does not hasten lesion resolution relative to administration of a placebo. Resistance to macrolides and rifampin in isolates of R equi is increasing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据